One of the most frequently studied markers has been the hypermethylation of RASSF1A [129,130,131,132,133], which discriminates between healthy individuals and BrCa patients and acts as a poor prognosis indicator [134]. This evidence concerns the gene RASSF1 and invasive breast carcinoma.